RPID - NASDAQ
Rapid Micro Biosystems, Inc.
$1.96
-0.51%Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in North America, Europe, and Asia. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and comprehensive customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides installation and verification, technical training, and support services. Its solutions are used in environmental monitoring, water testing, bioburden, and sterility release testing applications. The company was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. Rapid Micro Biosystems, Inc. was incorporated in 2006 and is headquartered in Lowell, Massachusetts.
At a Glance
Live SnapshotRapid Micro Biosystems, Inc. Funding & Solvency Profile
Financial Health Analysis
Current Ratio
Excellent liquidity position. The company can easily cover its short-term obligations with substantial cushion.
Debt-to-Equity Ratio
Elevated leverage. Debt exceeds equity, which amplifies both gains and risks. Monitor debt servicing ability.
Working Capital
Strong working capital position provides significant operational flexibility and financial cushion.
Asset Composition
Asset-light business model with high liquidity. Majority of assets are easily convertible to cash.
Rapid Micro Biosystems, Inc. Balance Sheet
RPID • NASDAQ
| Rapid Micro Biosystems, Inc. Balance Sheet | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
|---|---|---|---|---|---|---|---|
ASSETS | |||||||
CURRENT ASSETS | |||||||
20M | 16.9M | 24.3M | 27.1M | 178.4M | 30.1M | 12.5M | |
18.3M | 33.8M | 67.8M | 81.6M | 15.1M | 15M | 146K | |
38.3M | 50.7M | 92.1M | 108.6M | 193.5M | 45.1M | 12.5M | |
3.1M | 7.5M | 5.6M | 5.5M | 5.6M | 5.8M | 4.9M | |
3.1M | 7.5M | 5.5M | 5.4M | 5M | 5M | 3.6M | |
0.0 | 6K | 51K | 112K | 627K | 796K | 1.3M | |
17.6M | 20.2M | 20M | 21.2M | 15.7M | 9M | 5.8M | |
0.0 | 1.6M | 2.2M | 2.6M | 2.9M | 1.8M | 146K | |
2.1M | 843K | 577K | 705K | 440K | 546K | 336K | |
61.2M | 80.9M | 120.4M | 138.6M | 218.1M | 62.2M | 23.6M | |
NON-CURRENT ASSETS | |||||||
13.1M | 16.4M | 19.1M | 20.9M | 11.3M | 7.1M | 7.6M | |
0.0 | 365K | 2.9M | 29.8M | 10M | 0.0 | 152K | |
603K | 531K | 1.1M | 1.4M | 1.8M | 795K | 332K | |
13.7M | 17.3M | 23M | 52.1M | 23M | 7.8M | 8.1M | |
74.9M | 98.2M | 143.5M | 190.7M | 241.2M | 70M | 31.7M | |
LIABILITIES | |||||||
CURRENT LIABILITIES | |||||||
4.1M | 2.8M | 2.2M | 5.8M | 4.7M | 5.2M | 3.8M | |
4.1M | 2.5M | 2M | 5.4M | 3.9M | 4.5M | 3.2M | |
0.0 | 235K | 252K | 329K | 781K | 688K | 613K | |
0.0 | 2.4M | 4.7M | 4.1M | 6.1M | 3.1M | 2.2M | |
1.3M | 1.2M | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
0.0 | 0.0 | 1.1M | 766K | 0.0 | 0.0 | 0.0 | |
0.0 | 235K | 252K | 329K | 781K | 688K | 613K | |
4.7M | 6.6M | 6M | 4.7M | 3.3M | 4.4M | 1.9M | |
8.3M | 4.6M | 4.9M | 3.7M | 4M | 2.9M | 2.6M | |
18.5M | 17.6M | 19M | 19.1M | 18.2M | 15.5M | 10.5M | |
NON-CURRENT LIABILITIES | |||||||
22.6M | 0.0 | 0.0 | 0.0 | 0.0 | 24.8M | 17.8M | |
0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 705K | 683K | |
0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -705K | -683K | |
583K | 298K | 263K | 229K | 2M | 4.8M | 4.1M | |
23.2M | 5.3M | 6.5M | 7.4M | 2M | 29.6M | 21.9M | |
0.0 | 5M | 7.3M | 8M | 0.0 | 0.0 | 0.0 | |
41.6M | 22.8M | 25.5M | 26.5M | 20.2M | 45.2M | 32.4M | |
SHAREHOLDERS' EQUITY | |||||||
0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 151.8M | 81.9M | |
445K | 430K | 424K | 421K | 415K | 6K | 4K | |
0.0 | 550.2M | 546.1M | 540.8M | 535.7M | 114.6M | 121.9M | |
-522.4M | -475.3M | -428.4M | -375.9M | -315.1M | -241.6M | -204.5M | |
11K | 39K | -101K | -1.1M | -16K | 1K | 0.0 | |
555.1M | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 14K | |
33.2M | 75.4M | 118M | 164.2M | 221M | 24.8M | -725K | |
33.2M | 75.4M | 118M | 164.2M | 221M | 24.8M | -725K | |
SUMMARY | |||||||
74.9M | 98.2M | 143.5M | 190.7M | 241.2M | 70M | 31.7M | |
18.3M | 34.2M | 70.7M | 111.4M | 25.1M | 15M | 152K | |
23.9M | 6.2M | 7.3M | 8M | 0.0 | 24.8M | 17.8M | |
3.8M | -10.7M | -16.9M | -19.1M | -178.4M | -5.3M | 5.3M | |
44,024,709 | 44,024,709 | 44,024,709 | 44,024,709 | 44,024,709 | 44,024,709 | 44,024,709 |
SEC Filings
RPID - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | May 28, 2026 | May 21, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 19, 2026 | May 18, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | May 15, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 13, 2026 | May 13, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | April 08, 2026 | May 21, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 27, 2026 | March 23, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 12, 2026 | March 12, 2026 | 2026 | |
10-K 10-K 2025 FY FY | March 12, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | January 13, 2026 | January 13, 2026 | 2026 | |
10-Q 10-Q 2025 Q3 Q3 | November 07, 2025 | September 30, 2025 | 2025 |
Related Guides
Continue your RPID research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.